Global X Genomics & Biotechnology ETF (GNOM) Holdings $9.35 +0.21 (+2.30%) Closing price 03:59 PM EasternExtended Trading$9.35 0.00 (0.00%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Top 25 GNOM HoldingsRankCompanyCurrent PriceWeightShares Held1ALNYAlnylam Pharmaceuticals$454.38-2.8%6.42%6,9182CRSPCRISPR Therapeutics$54.32+2.8%5.62%43,4363ILMNIllumina$101.80+2.5%4.80%21,9524QGENQIAGEN$49.71+1.2%4.56%39,5505RNAAvidity Biosciences$46.35+3.8%4.52%54,5546LEGNLegend Biotech$35.56+0.1%4.37%48,8007TECHBio-Techne$57.09+5.7%4.23%33,3678MRNAModerna$27.12+3.4%4.02%63,0679BMRNBioMarin Pharmaceutical$58.58+0.9%3.63%27,02010VRTXVertex Pharmaceuticals$395.12-0.6%3.63%3,399 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11BNTXBioNTech$110.88+0.1%3.61%14,57512GHGuardant Health$61.40+0.2%3.51%36,67113NTRANatera$165.60+2.3%3.50%11,26514WGSGeneDx$128.66+6.6%3.20%13,63815Genscript Biotech CorporationN/A2.98%609,71816RAREUltragenyx Pharmaceutical$29.78+0.9%2.94%44,84717TWSTTwist Bioscience$28.59+8.0%2.40%30,90518ARWRArrowhead Pharmaceuticals$21.33+2.8%2.30%62,58019VCYTVeracyte$31.00+5.3%2.30%42,12620AAgilent Technologies$121.49+3.7%2.09%7,96621AstraZeneca PLCN/A2.07%6,08122BEAMBeam Therapeutics$16.64+3.9%2.05%47,08123GILDGilead Sciences$114.77-1.2%2.05%7,86224LLYEli Lilly and Company$710.73+0.1%1.77%1,00825BMYBristol Myers Squibb$47.84-1.2%1.76%17,234 Geographic ExposureUnited States82.0%Switzerland5.0%Netherlands4.2%Cayman Islands3.1%United Kingdom2.1%Singapore1.4%Currency ExposureUSD75.4%HKD3.1%GBP2.1%Sector ExposureHealth Care89.4%Consumer Discretionary4.9%Materials4.2%Energy0.4%Industry ExposureBiotechnology59.3%Health Care Equipment & Supplies15.2%Health Care Providers & Services8.1%Life Sciences Tools & Services5.4%Diversified Consumer Services4.9%Metals & Mining4.2%Pharmaceuticals1.4%Renewable Energy0.4%SubIndustry ExposureBiotechnology59.1%Life Sciences Tools & Services19.8%Health Care Services8.1%Diversified Metals & Mining4.2%Pharmaceuticals1.4%Health Care Equipment0.8%Renewable Energy Equipment0.4% Related Companies and Tools Related Companies DEMZ Holdings BLCN Holdings FMET Holdings MOOD Holdings FDNI Holdings HRTS Holdings TEKY Holdings KOID Holdings FMED Holdings FDFF Holdings This page (NASDAQ:GNOM) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access